Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Randomized Trial Evaluating FOLFIRI Plus Cetuximab Versus FOLFIRI Plus Bevacizumab in First Line Treatment of Metastatic Colorectal Cancer.

NCT00433927 is registered in ClinicalTrials.gov with PD Dr. med. Volker Heinemann as lead sponsor.

NCT NCT00433927
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00433927 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Randomized Trial Evaluating FOLFIRI Plus Cetuximab Versus FOLFIRI Plus Bevacizumab in First Line Treatment of Metastatic Colorectal Cancer.
Lead sponsor
PD Dr. med. Volker Heinemann
Phase
Phase 3
Overall status
Unknown status
Start date
January 31, 2007
Completion date
December 31, 2016
Enrollment
568 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer, neoplasm metastasis